Regen Biowellness

Hauppauge, United States Founded: 2020 • Age: 6 yrs Acquired By Emergent Health Company
Plant-based drugs are distributed by Regen Biowellness.

About Regen Biowellness

Regen Biowellness is a Healthcare company based in Hauppauge (United States) founded in 2020, and was acquired by Emergent Health Company in August 2022. Plant-based drugs are distributed by Regen Biowellness. Its focus areas include Pharmaceutical Distributors, Alternative Medicines and Ayurvedic Medicines.

Company details

Regen Biowellness was founded in 2020 and is based in Hauppauge, United States. Operations focus on the distribution of plant-based drugs within the biowellness sector. Products are sourced and supplied to various markets, emphasizing natural wellness solutions. The companys domain, regenbiowellness.tcc.mode, supports online presence and transactions. Activities are conducted primarily in the United States, with an emphasis on regulatory compliance in pharmaceutical distribution.

  • Headquarters Hauppauge, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Acquired by Emergent Health Company (Aug 2022)
Key Metrics

Investors in Regen Biowellness

Regen Biowellness has secured backing from 1 investor. Prominent investors backing the company include Emergent Health Company.

All
InvestorDescriptionFounded YearDomainLocation
emergenthealthcompany.com
Premium access

Investor details for Regen Biowellness

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Regen Biowellness

2 dated milestones of Regen Biowellness across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Regen Biowellness is founded.
  2. Exit Acquired by Emergent Health Company.

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Regen Biowellness (Alternative Medicine Products) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical therapies for smell and taste loss are developed.
2014Washington, District Of Columbia, United StatesUSD 25.88 M
Homeopathic medicines are supplied and distributed by Boiron worldwide.
1932Newtown Square, Pennsylvania, United States
Manufacturer of herbal medicines
2009Wilmington, Delaware, United StatesUSD 2.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Regen Biowellness

Regen Biowellness was founded in 2020.

Regen Biowellness is headquartered in Hauppauge, United States. It is registered at Hauppauge, New York, United States.

Regen Biowellness was founded in 2020 and is based in Hauppauge, United States. Operations focus on the distribution of plant-based drugs within the biowellness sector. Products are sourced and supplied to various markets, emphasizing natural wellness solutions. The companys domain, regenbiowellness.tcc.mode, supports online presence and transactions. Activities are conducted primarily in the United States, with an emphasis on regulatory compliance in pharmaceutical distribution.

Regen Biowellness has 1 investor. Key investors include Emergent Health Company.

Yes. Regen Biowellness was acquired by Emergent Health Company in August 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available